ME Therapeutics Holdings Inc (METX) Stock Price & News

All values in CAD	2025-ж. авг.	2025-ж. ноя.	2026-ж. фев.	2026-ж. май
Revenue	-	-	-	-
Cost of goods sold	-	-	-	-
Cost of revenue	-	-	-	-
Research and development expenses	165,08 миң	141,84 миң	178,41 миң	245,32 миң
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	209,58 миң	213,56 миң	124,66 миң	163,76 миң
Operating expense	401,22 миң	381,91 миң	331,36 миң	436,48 миң
Total operating expenses	401,22 миң	381,91 миң	331,36 миң	436,48 миң
Operating income	-401,22 миң	-381,91 миң	-331,36 миң	-436,48 миң
Other non operating income	57,29 миң	23,69 миң	39,50 миң	35,46 миң
EBT including unusual items	-338,41 миң	-354,43 миң	-289,22 миң	-398,35 миң
EBT excluding unusual items	-338,41 миң	-354,43 миң	-289,22 миң	-398,35 миң
Income tax expense	-	-	-	-
Effective tax rate	-	-	-	-
Other operating expenses	-	-	-	-
Net income	-338,41 миң	-354,43 миң	-289,22 миң	-398,35 миң
Net profit margin	-	-	-	-
Earnings per share	-	-	-	-
Interest and investment income	8,34 миң	6,10 миң	4,39 миң	3,87 миң
Interest expense	-2,82 миң	-2,31 миң	-1,76 миң	-1,20 миң
Net interest expenses	5,52 миң	3,79 миң	2,63 миң	2,68 миң
Depreciation and amortization charges	26,56 миң	26,52 миң	28,28 миң	27,40 миң
EBITDA	-388,82 миң	-369,59 миң	-317,26 миң	-423,28 миң
Gain or loss from assets sale	-	-	-	-

Ask anything